Trifluoroacetic acid → N-{3-[3-(Aminomethyl)phenyl]-2,6-dimethylthieno[2,3-b]pyridin-4-yl}-3-chlorobenzenesulfonamide
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4]([S:8]([NH:11][C:12]2[CH:17]=[C:16]([CH3:18])[N:15]=[C:14]3[S:19][C:20]([CH3:37])=[C:21]([C:22]4[CH:23]=[C:24]([CH2:28][NH:29]C(=O)OC(C)(C)C)[CH:25]=[CH:26][CH:27]=4)[C:13]=23)(=[O:10])=[O:9])[CH:5]=[CH:6][CH:7]=1.C(O)(C(F)(F)F)=O>C(Cl)Cl>[NH2:29][CH2:28][C:24]1[CH:23]=[C:22]([C:21]2[C:13]3[C:14](=[N:15][C:16]([CH3:18])=[CH:17][C:12]=3[NH:11][S:8]([C:4]3[CH:5]=[CH:6][CH:7]=[C:2]([Cl:1])[CH:3]=3)(=[O:9])=[O:10])[S:19][C:20]=2[CH3:37])[CH:27]=[CH:26][CH:25]=1Participants
4
Procedure
To a solution of 1,1-dimethylethyl {[3-(4-{[(3-chlorophenyl)sulfonyl]amino}-2,6-dimethylthieno[2,3-b]pyridin-3-yl)phenyl]methyl}carbamate (Example 70) (40 mg, 0.072 mmol) in DCM (2 mL) was added TFA (0.276 mL, 3.58 mmol) and the mixture stirred for 1 h. The mixture was then loaded onto an SCX cartridge and flushed with MeOH (3×5 mL) followed by 2M NH3 in MeOH (3×5 mL). The desired fractions were combined and concentrated and further purified by normal phase chromatography, eluting with a gradient of 0-20% 2M NH3 in MeOH in DCM, to give the title compound (2.8 mg). LCMS (A) m/z: 458 [M+1]+, Rt 0.96 min (basic).
Workup
- customflushed with MeOH (3×5 mL)
- concentrationconcentrated
- customfurther purified by normal phase chromatography
- washeluting with a gradient of 0-20% 2M NH3 in MeOH in DCM
Sources & evidence
- ORD record
- ord-91d880a71a14470f83a565597fe1ff4e
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09029545B2
Reaction notes
Loading…